Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients

Ann Acad Med Singapore. 2019 Sep;48(9):301-305.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Autoimmune Diseases
  • Cyclosporine / therapeutic use
  • Disease Management
  • Enzyme Inhibitors / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Hydroxyurea / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Methotrexate / therapeutic use
  • Middle Aged
  • Mycophenolic Acid / therapeutic use
  • Pemphigoid, Bullous / complications
  • Pemphigoid, Bullous / drug therapy*
  • Pemphigus / complications
  • Pemphigus / drug therapy*
  • Psoriasis / complications
  • Psoriasis / therapy*
  • Retrospective Studies
  • Ultraviolet Therapy

Substances

  • Enzyme Inhibitors
  • Glucocorticoids
  • Immunosuppressive Agents
  • Cyclosporine
  • Mycophenolic Acid
  • Hydroxyurea
  • Methotrexate